Hem n Onc 8-8 (12) Flashcards
This patient presents with “B symptoms” (fever, night sweats, weight loss), signs of tumor lysis syndrome (oliguria), and a solitary jaw mass. This presentation, along with the results of the biopsy, suggest a diagnosis of Burkitt lymphoma, a lymphoma endemic to Africa and known to be associated with Epstein-Barr virus (EBV), which is a?
linear double-stranded DNA virus. The cytogenetic abnormality associated with Burkitt lymphoma is a t(8;14) translocation, in which the oncogene c-myc is placed under the expression of the immunoglobulin heavy-chain enhancer. In regions where the disease is endemic, children are typically infected with EBV by the age of 3 years, whereas infection typically occurs during adolescence in other regions.
Since the Burkitt lymphoma tumor (like other aggressive lymphomas) exhibits a high mitotic index and has many apoptotic cells, the nuclear remnants are phagocytosed by macrophages. The phagocytes have abundant clear cytoplasm, creating the characteristic “starry sky” appearance, in which sheets of lymphocytes are interspersed with occasional macrophages, shown here.
The other viruses do not explain this patient’s symptoms:
An example of a circular partially double-stranded DNA virus is hepatitis B virus (HBV) which causes hepatitis.
Parvovirus B19 is?
a linear negative-sense single-stranded DNA virus that causes aplastic crises in sickle cell disease, erythema infectiosum (fifth disease) in children, and hydrops fetalis in fetuses.
Rotavirus is a linear positive-sense segmented double-stranded RNA virus that causes diarrhea in young children.
A linear positive-sense single-stranded RNA virus is hepatitis A. Individuals would likely present with gastrointestinal symptoms and will likely have had a history of recent travel.
This patient presents with fever, hypotension (a common cause of syncope), dermatologic manifestations, and multisystem organ involvement. In this case, the lab values indicate hepatic, renal, and hematologic pathology. This clinical picture suggests a diagnosis of?
staphylococcal toxic shock syndrome. At least three of the following organ systems are typically involved:
Gastrointestinal (nausea/vomiting)
Muscular (myalgia with elevated creatine phosphokinase level)
Renal (elevated serum blood urea nitrogen and/or creatinine levels, or pyuria)
Hepatic (elevated aspartate aminotransferase, alanine aminotransferase, and/or bilirubin)
Hematologic (platelet count <100,000/mm3, leukocytosis)
Central nervous system (altered mentation/consciousness without focal findings).
Disseminated intravascular coagulopathy (DIC) is often precipitated by gram-negative sepsis, but this patient’s lab values are inconsistent with DIC.
Hemolytic-uremic syndrome is seen in infants and children. It is characterized by a triad of hemolytic anemia (anemia caused by destruction of red blood cells), acute kidney failure (uremia), and a low platelet count (thrombocytopenia).
Rocky Mountain spotted fever (RMSF) usually causes a?
characteristic rash that involves the soles and palms. Symptoms include fever, headache, and muscle aches.
Stevens-Johnson syndrome is caused by a reaction to a medication or infection and manifests with a blistering rash on the skin.
Staphylococcal toxic shock syndrome, caused by the massive cytokine release in response to exotoxin, may manifest systemically with?
fever and hypotension and involve multiple organ systems. Palmar/plantar desquamation is a hallmark feature, but it does not occur until approximately 2 weeks after onset.
This patient received a bone marrow transplant, which puts her at risk for graft-versus-host disease. Graft-versus-host disease (GVHD) is a severe adverse immunologic reaction following this procedure, brought on by the reaction of donor T cells to recipient histoincompatible antigens. Cyclosporine is an ?
immunosuppressant and is often used in transplant recipients to control GVHD that may result from allogeneic bone transplant. The drug inhibits transcription of interleukin-2 and other cytokines important for T-lymphocyte activation, thus dampening the cell-mediated immune response. Cyclosporine has potential renal toxicity, which exacerbates this patient’s poor renal function, as evidenced by her high creatinine. Therefore, cyclosporine should be used with caution in this patient.
Azathioprine is a prodrug for the immunosuppressant 6-mercaptopurine, but neither agent causes significant renal toxicity.
Dacluzimab is an interleukin-2 receptor antagonist and muromab-CD3 is a CD3 receptor antagonist. Neither causes marked renal impairment effects.
Mycophenolate is an IMPDH inhibitor preventing the synthesis of?
purines.
Like azathioprine, bone marrow suppression is the worrisome side effect, not renal toxicity.
Glucocorticosteroids like prednisone do not cause appreciable renal damage.
This patient presents with complaints of fatigue, weight loss, and anorexia, along with a bulging mass extending from the left costal margin toward his right lower quadrant. The lymph node biopsy reveals a diffuse infiltrate of small, round, mature-appearing lymphocytes with minimal cytoplasm, which, along with his lymphadenopathy, is indicative of?
small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL). The disease is a monoclonal B-lymphocyte neoplasm that affects the peripheral blood, bone marrow, and lymph nodes.
SLL-CLL is considered as one disease entity, with SLL representing disease restricted to tissues without blood involvement. Patients usually present with painless, generalized lymphadenopathy and splenomegaly and sometimes complain of fevers, night sweats, and weight loss.
SLL can eventually transform to diffuse large B-cell lymphoma via the Richter process, but the morphology of the cells (large, basophilic cytoplasm, disorganized cell morphology) is not seen in this patient’s histologic slide.
Follicular lymphoma results in ?
nodular architecture but not diffuse growth of lymphocytes.
Infectious mononucleosis manifests with high fever, pharyngitis, and lymphadenopathy in adolescents and may lead to Burkitt lymphoma.
This patient’s fatigue and pallor suggest anemia. His blood work demonstrates microcytic anemia (MCV < 80 fL) with basophilic stippling (RBCs with dark-purple, punctate inclusions). Together, these are highly suggestive of lead poisoning. His poor concentration and myalgias and his history of working in a shipyard further support the diagnosis of lead poisoning.
Lead poisoning inhibits?
aminolevulinic acid (ALA) dehydratase, an early enzyme in the hemoglobin synthesis pathway (shown above), resulting in the accumulation of ALA in the serum and urine. ALA synthase irreversibly catalyzes the first reaction of hemoglobin synthesis: glycine + succinyl-coenzyme A → ALA. This is the rate-limiting and committed step of heme synthesis (therefore, it would not cause accumulation of glycine or succinyl-coenzyme A).
ALA dehydratase then catalyzes the second step in heme synthesis: 2 ALA → porphobilinogen (therefore, porphobilinogen levels would decrease [not increase] in lead poisoning). Elevated serum lead inhibits?
sulfhydryl-dependent enzymes, including ALA dehydratase (ferrochelatase, an enzyme later in the heme synthesis pathway, is also inactivated by high lead levels). Because ALA synthase’s action is irreversible, only ALA accumulates.
ALA is found only in the urine when blood lead levels are very high, so a thorough history and findings such as microcytic anemia and long-bone lead lines on X-ray are often more useful in making the diagnosis.
Uroporphyrinogen III levels increase in porphyria cutanea tarda.
Prevalence is the measure of how commonly a disease or condition occurs in a population. In other words, prevalence is used as a way to describe how much of a disease is present in a population at a specific point in time. In this question we are asked to determine the prevalence of sickle cell disease in a specific population after 1 year. Let’s jot down some numbers. The initial prevalence is 10%; this means?
that of the total population there are (10% × 6000), or 600 cases of sickle cell disease. Over the course of the year there are 6 additional sickle cell births and 3 existing sickle cell patients who die, for a net gain of 3. Thus, in this population there are 603 sickle cell cases at the end of the year.
The total population also changes during the year. There are 100 births and 80 deaths, for a net gain of 20. Thus, the total population at the end of the year is 6020. Consequently, the prevalence in this population after one year is 603/6020, or 10.01%.
If you chose 6/100 or 6/6020, then you are likely confusing prevalence with incidence. The incidence of sickle cell disease is calculated as the number of new cases (6 affected newborns) divided by the number of people at risk (100 newborns). Note that the denominator for incidence is only 100, because the original 6000 subjects were already genotyped and are not at risk.
The other choices are incorrect for various reasons:
3/6020 describes?
the net gain in the number of cases divided by the population at risk; it doesn’t take into account the initial 600 cases in the numerator.
603/6000 does not take into account the births and deaths that occurred during the year, which would affect the denominator.
606/6100 fails to reflect the deaths that occurred during the year, which would affect both the total number of cases and the population at the end of the year.
HIV-positive patients who stop their HAART are at risk of developing viral rebound and AIDS-defining illness. This patient has the cutaneous lesions of Kaposi sarcoma, which are malignant proliferations of spindle cells and endothelial cells. Kaposi sarcoma arises in the setting of human herpes virus 8 infection in the immunocompromised host and is an AIDS-defining illness in patients with HIV infection.
Although cutaneous lesions are striking, lesions can appear in and affect any organ system in the body, most commonly?
the lungs, gastrointestinal tract, and biliary tree. Fifty percent of patients have gastrointestinal involvement, which often presents as mucosal bleeding leading to hematochezia, hematemesis, and/or melena (black stools).
Note that severely immunocompromised patients may also develop bacillary angiomatosis, a severe consequence of Bartonella infection. The skin eruptions may look very much like Kaposi sarcoma, but there are several key differences. A biopsy will reveal Kaposi sarcoma to be a vascular tumor, whereas bacteria will be identified on a skin biopsy specimen from a patient with bacillary angiomatosis.
Staining with Warthin-Starry special stain highlights?
the bacterial colonies. Seizures in patients with HIV infection are not associated with Kaposi sarcoma, which very rarely manifests in the central nervous system. Although patients with HIV infection may have arthritis or bradycardia, arthritis and bradycardia are not caused by Kaposi sarcoma. Alopecia and excessive tearing are not associated with Kaposi sarcoma in the setting of HIV infection.